🔎 Trials Near Me

Hjem › Burkitts lymfom › Pennsylvania › Philadelphia

Kliniske studier for Burkitts lymfom i Philadelphia, PA

16 studier for Burkitts lymfom søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

RekruttererFase 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Alder 1 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

RekruttererFase 1
  • Children's Hospital of Philadelphia, Philadelphia
Alder 0 til 18 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi unna
366 Days – 46 Years · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

RekruttererFase 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Alder 18 til 39 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT03150693

Blinatumomab Consolidation in Real World

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • University of Pennsylvania, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RekruttererObservasjonsstudie
  • Children's Hospital of Philadelphia, Philadelphia
Alder 0 til 38 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi unna
365 Days · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekruttererFase 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi unna
Alder 1 til 30 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi unna
365 Days – 25 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekruttererFase 2
  • Children's Hospital of Philadelphia, Philadelphia
Alder 7 til 25 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Rekrutterer
  • Children's Hospital of Philadelphia, Philadelphia
Opp til 25 år · Alle kjønn · Oppdatert 8. jul. 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

RekruttererFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Alder 0 til 29 · Alle kjønn · Oppdatert 26. mai 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

RekruttererFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Opp til 29 år · Alle kjønn · Oppdatert 27. mar. 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

RekruttererFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Alder 15 til 50 · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RekruttererFase 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi unna
Alder 1 til 25 · Alle kjønn · Oppdatert 4. mai 2025 · NCT03509961

Burkitts lymfom-studier i andre byer

Andre studier i Philadelphia

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.